{"transactions":[{"id":791316,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-05T20:40:50.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":152783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the \"Plan\"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan)."}],"balance_after":152783,"derivative":{"exercise_price":0.841,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":152783},"source":{"system":"sec-edgar","filing":"0001213900-26-052256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000121390026052256/ownership.xml","form_type":"4"}},{"id":1013110,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-27T21:26:45.000Z","date":"2025-10-24","kind":"grant","planned":false,"acquired":true,"shares":42913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the \"Plan\"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan)."}],"balance_after":42913,"derivative":{"exercise_price":0.715,"expiration_date":"2035-10-23","underlying":"Common Stock","underlying_shares":42913},"source":{"system":"sec-edgar","filing":"0001213900-25-102680","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000121390025102680/ownership.xml","form_type":"4"}},{"id":1478629,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T21:25:21.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":5.62,"value":15455.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.55 to $5.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001213900-24-053005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000121390024053005/ownership.xml","form_type":"4"}},{"id":1478628,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T21:25:21.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":750,"price":5.61,"value":4207.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.60 to $5.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001213900-24-053005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000121390024053005/ownership.xml","form_type":"4"}},{"id":1546505,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-06T01:45:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on March 1, 2024, was $8.13 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option award (the \"Option\") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date."}],"balance_after":5000,"derivative":{"exercise_price":8.13,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-24-030960","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000121390024030960/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1606454,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T02:46:39.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award (the \"Option\") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date."}],"balance_after":5000,"derivative":{"exercise_price":8.34,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-24-019220","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000121390024019220/ownership.xml","form_type":"4"}},{"id":2132819,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (to acquire Common Stock)","published_at":"2022-10-24T14:15:40.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to Mr. Novak's continued service as a director, one-half vesting on the first anniversary of the grant date, and the remaining 50% vesting on the second anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":1.06,"exercise_date":"2023-10-21","expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-22-065696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000121390022065696/ownership.xml","form_type":"4"}},{"id":2227076,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-17T20:25:41.000Z","date":"2022-06-15","kind":"exercise","acquired":false,"shares":1346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 15, 2021, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2022, subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 15, 2021, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2022, subject to continued service during the vesting period and the award agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1346},"source":{"system":"sec-edgar","filing":"0001639691-22-000067","document":"wf-form4_165549751888453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969122000067/wf-form4_165549751888453.xml","form_type":"4"}},{"id":2227075,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-17T20:25:41.000Z","date":"2022-06-15","kind":"tax_withholding","acquired":false,"shares":97,"price":59.94,"value":5814.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability."}],"balance_after":12617,"source":{"system":"sec-edgar","filing":"0001639691-22-000067","document":"wf-form4_165549751888453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969122000067/wf-form4_165549751888453.xml","form_type":"4"}},{"id":2227074,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-17T20:25:41.000Z","date":"2022-06-15","kind":"exercise","acquired":true,"shares":1346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":12714,"source":{"system":"sec-edgar","filing":"0001639691-22-000067","document":"wf-form4_165549751888453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969122000067/wf-form4_165549751888453.xml","form_type":"4"}},{"id":2514490,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-11-12T22:50:27.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":2337,"price":89.1729,"value":208397.0673,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average selling price.  Securities sold through 21 separate sales on the transaction date at prices ranging from $88.89 to $89.71.  The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11368,"source":{"system":"sec-edgar","filing":"0001639691-21-000113","document":"wf-form4_163675739365213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969121000113/wf-form4_163675739365213.xml","form_type":"4"}},{"id":2514489,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-11-12T22:50:27.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":644,"price":90.7659,"value":58453.2396,"ownership":{"direct":true},"balance_after":13705,"source":{"system":"sec-edgar","filing":"0001639691-21-000113","document":"wf-form4_163675739365213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969121000113/wf-form4_163675739365213.xml","form_type":"4"}},{"id":2647227,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-01T22:59:24.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":2337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 29, 2020, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 29, 2021, subject to continued service during the vesting period and the RSU Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 29, 2020, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 29, 2021, subject to continued service during the vesting period and the RSU Agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the number of derivative securities beneficially owned following reported transaction for this specific grant."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2337},"source":{"system":"sec-edgar","filing":"0001639691-21-000076","document":"wf-form4_162518031067482.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969121000076/wf-form4_162518031067482.xml","form_type":"4"}},{"id":2647226,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-07-01T22:59:24.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":2337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":14349,"source":{"system":"sec-edgar","filing":"0001639691-21-000076","document":"wf-form4_162518031067482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969121000076/wf-form4_162518031067482.xml","form_type":"4"}},{"id":2665732,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-16T23:58:37.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":1346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 15, 2021, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2022, subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 15, 2021, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2022, subject to continued service during the vesting period and the award agreement."}],"balance_after":1346,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1346},"source":{"system":"sec-edgar","filing":"0001639691-21-000061","document":"wf-form4_162388790473086.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969121000061/wf-form4_162388790473086.xml","form_type":"4"}},{"id":2989429,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-11-06T23:35:53.000Z","date":"2020-06-18","kind":"tax_withholding","acquired":false,"shares":58,"price":48.29,"value":2800.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Form 4 is being amended to revise the number of shares withheld from distribution to satisfy tax liability due to an administrative error."}],"balance_after":12012,"source":{"system":"sec-edgar","filing":"0001639691-20-000115","document":"wf-form4a_160470573768256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969120000115/wf-form4a_160470573768256.xml","form_type":"4/A","original_submission_date":"2020-06-22"}},{"id":3094931,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-01T20:33:22.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":2337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share (Ordinary Share) of LivaNova PLC (the Company), GBP 1.00 par value,  in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 29, 2021, subject to continued service during the vesting period and the RSU Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 29, 2021, subject to continued service during the vesting period and the RSU Agreement."}],"balance_after":2337,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2337},"source":{"system":"sec-edgar","filing":"0001639691-20-000085","document":"wf-form4_159363552205140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969120000085/wf-form4_159363552205140.xml","form_type":"4"}},{"id":3102852,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-22T22:03:03.000Z","date":"2020-06-18","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one Ordinary Share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 18 2020, subject to continued service during the vesting period and the RSU Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 18 2020, subject to continued service during the vesting period and the RSU Agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001639691-20-000073","document":"wf-form4_159286335897525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969120000073/wf-form4_159286335897525.xml","form_type":"4"}},{"id":3102851,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-22T22:03:03.000Z","date":"2020-06-18","kind":"tax_withholding","acquired":false,"shares":675,"price":48.29,"value":32595.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability."}],"balance_after":11395,"source":{"system":"sec-edgar","filing":"0001639691-20-000073","document":"wf-form4_159286335897525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969120000073/wf-form4_159286335897525.xml","form_type":"4"}},{"id":3102850,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-22T22:03:03.000Z","date":"2020-06-18","kind":"exercise","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":12070,"source":{"system":"sec-edgar","filing":"0001639691-20-000073","document":"wf-form4_159286335897525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969120000073/wf-form4_159286335897525.xml","form_type":"4"}},{"id":3108529,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-16T21:12:08.000Z","date":"2020-06-16","kind":"purchase","acquired":true,"shares":1000,"price":46.713,"value":46713.0,"ownership":{"direct":true},"balance_after":10570,"source":{"system":"sec-edgar","filing":"0001639691-20-000068","document":"wf-form4_159234190973538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969120000068/wf-form4_159234190973538.xml","form_type":"4"}},{"id":3374609,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-12T16:39:30.000Z","date":"2019-11-12","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting monthly over one year from the grant date and in any event will be fully vested on the date of the next annual meeting of our stockholders, was accelerated and canceled in the Merger in exchange for a cash payment of $181,400.00, representing the difference between the exercise price of outstanding shares subject to the option and the market value of the underlying common stock on the effective date of the Merger ($27.50 per share). In addition, one non-transferable contingent value right per share, which represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone was awarded to the Reporting Person for each outstanding share subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting monthly over one year from the grant date and in any event will be fully vested on the date of the next annual meeting of our stockholders, was accelerated and canceled in the Merger in exchange for a cash payment of $181,400.00, representing the difference between the exercise price of outstanding shares subject to the option and the market value of the underlying common stock on the effective date of the Merger ($27.50 per share). In addition, one non-transferable contingent value right per share, which represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone was awarded to the Reporting Person for each outstanding share subject to the option."}],"balance_after":0,"derivative":{"exercise_price":9.36,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119056042/doc4.xml","form_type":"4"}},{"id":3374608,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-12T16:39:30.000Z","date":"2019-11-12","kind":"disposition_to_issuer","acquired":false,"shares":33000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting over a period of three years as follows: (i) one-third of the total shares subject to the option shall vest on May 25, 2018, and (ii) 1/36th of total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, was accelerated and canceled in the Merger in exchange for a cash payment of 665,940.00, representing the difference between the exercise price of outstanding shares subject to the option and the market value of the underlying common stock on the effective date of the Merger ($27.50 per share). In addition, one non-transferable contingent value right per share, which represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone was awarded to the Reporting Person for each outstanding share subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting over a period of three years as follows: (i) one-third of the total shares subject to the option shall vest on May 25, 2018, and (ii) 1/36th of total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, was accelerated and canceled in the Merger in exchange for a cash payment of 665,940.00, representing the difference between the exercise price of outstanding shares subject to the option and the market value of the underlying common stock on the effective date of the Merger ($27.50 per share). In addition, one non-transferable contingent value right per share, which represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone was awarded to the Reporting Person for each outstanding share subject to the option."}],"balance_after":0,"derivative":{"exercise_price":7.32,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-19-056042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119056042/doc4.xml","form_type":"4"}},{"id":3374607,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-12T16:39:30.000Z","date":"2019-11-12","kind":"disposition_to_issuer","acquired":false,"shares":6901,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed pursuant to an agreement and plan of merger by and between the Issuer, Swedish Orphan Biovitrum AB and Dragonfly Acquisition Corp. (the \"Merger\") in exchange for $27.50 per share of Issuer's common stock including any shares subject to each restricted stock unit on the effective date of the Merger, plus (ii) one non-transferable contingent value right per share, which  represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to an agreement and plan of merger by and between the Issuer, Swedish Orphan Biovitrum AB and Dragonfly Acquisition Corp. (the \"Merger\") in exchange for $27.50 per share of Issuer's common stock including any shares subject to each restricted stock unit on the effective date of the Merger, plus (ii) one non-transferable contingent value right per share, which  represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119056042/doc4.xml","form_type":"4"}},{"id":3482242,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-20T20:57:47.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share (Ordinary Share) of LivaNova PLC (the Company), GBP 1.00 par value,  in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 18 2020, subject to continued service during the vesting period and the RSU Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 18 2020, subject to continued service during the vesting period and the RSU Agreement."}],"balance_after":1500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001639691-19-000105","document":"wf-form4_156106425222826.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969119000105/wf-form4_156106425222826.xml","form_type":"4"}},{"id":3485800,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-18T20:23:08.000Z","date":"2019-06-15","kind":"exercise","acquired":false,"shares":1048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one Ordinary Share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reporting person was granted RSUs that vested and all forfeiture restrictions thereon lapsed on June 15, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reporting person was granted RSUs that vested and all forfeiture restrictions thereon lapsed on June 15, 2019."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1048},"source":{"system":"sec-edgar","filing":"0001639691-19-000087","document":"wf-form4_156088937380962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969119000087/wf-form4_156088937380962.xml","form_type":"4"}},{"id":3485799,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-18T20:23:08.000Z","date":"2019-06-15","kind":"tax_withholding","acquired":false,"shares":472,"price":71.93,"value":33950.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability."}],"balance_after":9570,"source":{"system":"sec-edgar","filing":"0001639691-19-000087","document":"wf-form4_156088937380962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969119000087/wf-form4_156088937380962.xml","form_type":"4"}},{"id":3485798,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-18T20:23:08.000Z","date":"2019-06-15","kind":"exercise","acquired":true,"shares":1048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares (Ordinary Shares) of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":10042,"source":{"system":"sec-edgar","filing":"0001639691-19-000087","document":"wf-form4_156088937380962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969119000087/wf-form4_156088937380962.xml","form_type":"4"}},{"id":3531195,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-10T16:34:06.000Z","date":"2019-05-09","kind":"sale","acquired":false,"shares":1300,"price":70.6322,"value":91821.86,"ownership":{"direct":true},"balance_after":8994,"source":{"system":"sec-edgar","filing":"0001639691-19-000078","document":"wf-form4_155750603095142.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969119000078/wf-form4_155750603095142.xml","form_type":"4"}},{"id":3545601,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-30T16:33:57.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting monthly over one year from the grant date and in any event will be fully vested on the date of the next annual meeting of our stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":9.36,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-026572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119026572/doc4.xml","form_type":"4"}},{"id":3670464,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-07T16:57:32.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":6901,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests 50% on each of June 30, 2019 and 25% on each of September 30, 2019 and December 31, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."}],"balance_after":6901,"source":{"system":"sec-edgar","filing":"0001209191-19-008112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119008112/doc4.xml","form_type":"4"}},{"id":3726340,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-12-18T21:24:17.000Z","date":"2018-12-15","kind":"exercise","acquired":false,"shares":1715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 15, 2017, reporting person was granted RSUs that vested and all forfeiture restrictions thereon lapsed on December 15, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 15, 2017, reporting person was granted RSUs that vested and all forfeiture restrictions thereon lapsed on December 15, 2018."}],"balance_after":1048,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1715},"source":{"system":"sec-edgar","filing":"0001639691-18-000120","document":"wf-form4_154516823973789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969118000120/wf-form4_154516823973789.xml","form_type":"4"}},{"id":3726339,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-12-18T21:24:17.000Z","date":"2018-12-15","kind":"tax_withholding","acquired":false,"shares":771,"price":94.45,"value":72820.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability."}],"balance_after":10294,"source":{"system":"sec-edgar","filing":"0001639691-18-000120","document":"wf-form4_154516823973789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969118000120/wf-form4_154516823973789.xml","form_type":"4"}},{"id":3726338,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-12-18T21:24:17.000Z","date":"2018-12-15","kind":"exercise","acquired":true,"shares":1715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":11065,"source":{"system":"sec-edgar","filing":"0001639691-18-000120","document":"wf-form4_154516823973789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969118000120/wf-form4_154516823973789.xml","form_type":"4"}},{"id":3731835,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-12-13T23:47:35.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":500,"price":97.1601,"value":48580.05,"ownership":{"direct":true},"balance_after":9350,"source":{"system":"sec-edgar","filing":"0001639691-18-000117","document":"wf-form4_154474483913819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969118000117/wf-form4_154474483913819.xml","form_type":"4"}},{"id":3886172,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-21T16:27:05.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over the 12 months commencing on July 19, 2018, provided that the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":30.11,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-038948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919118038948/doc4.xml","form_type":"4"}},{"id":3890338,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-18T21:13:13.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":1048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share (Ordinary Share) of LivaNova PLC (the Company), GBP 1.00 par value,  in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on June 15, 2019.  The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on June 15, 2019.  The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."}],"balance_after":2763,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1048},"source":{"system":"sec-edgar","filing":"0001639691-18-000067","document":"wf-form4_152935637043770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969118000067/wf-form4_152935637043770.xml","form_type":"4"}},{"id":3890337,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-18T21:13:13.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":1000,"price":104.431,"value":104431.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average selling price.  Securities sold through approximately 2 separate sales on the transaction date at prices ranging from $104.42 to $104.53.  The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9850,"source":{"system":"sec-edgar","filing":"0001639691-18-000067","document":"wf-form4_152935637043770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969118000067/wf-form4_152935637043770.xml","form_type":"4"}},{"id":3936697,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-11T14:07:29.000Z","date":"2018-05-09","kind":"sale","acquired":false,"shares":1000,"price":84.0164,"value":84016.4,"ownership":{"direct":true},"balance_after":10850,"source":{"system":"sec-edgar","filing":"0001639691-18-000047","document":"wf-form4_152604758922692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969118000047/wf-form4_152604758922692.xml","form_type":"4"}},{"id":4125963,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-12-19T21:52:47.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":1715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share (\"Ordinary Share\") of LivaNova PLC (the \"Company\") or, at the option of the Company, a cash settlement in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on December 15, 2018.  The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on December 15, 2018.  The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan."}],"balance_after":1715,"derivative":{"underlying":"Common Stock","underlying_shares":1715},"source":{"system":"sec-edgar","filing":"0001639691-17-000108","document":"wf-form4_151372035364852.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969117000108/wf-form4_151372035364852.xml","form_type":"4"}},{"id":4151598,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-24T13:17:04.000Z","date":"2017-11-22","kind":"sale","acquired":false,"shares":2000,"price":85.7693,"value":171538.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average selling price.  Securities sold through approximately 16 separate sales on the transaction date at prices ranging from $85.63 to $85.83.  The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11850,"source":{"system":"sec-edgar","filing":"0001639691-17-000100","document":"wf-form4_151152940978626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969117000100/wf-form4_151152940978626.xml","form_type":"4"}},{"id":4239816,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-08T23:52:17.000Z","date":"2017-08-05","kind":"exercise","acquired":false,"shares":3327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reporting person was granted restricted stock units (\"RSUs\") settled in ordinary share of LivaNova PLC (the \"Company\"), GBP 1.00 par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 5, 2016, reporting person was granted RSUs that vested and all forfeiture restrictions thereon lapsed on August 5, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 5, 2016, reporting person was granted RSUs that vested and all forfeiture restrictions thereon lapsed on August 5, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3327},"source":{"system":"sec-edgar","filing":"0001639691-17-000075","document":"wf-form4_150223632299871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969117000075/wf-form4_150223632299871.xml","form_type":"4"}},{"id":4239815,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-08T23:52:17.000Z","date":"2017-08-05","kind":"tax_withholding","acquired":false,"shares":1497,"price":60.41,"value":90433.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The referenced shares were withheld from distribution at the request of reporting person.  Such shares were forfeited and the associated value was used to offset the tax liability associated with the August 5, 2017 vesting of 3,327 RSUs."}],"balance_after":13850,"source":{"system":"sec-edgar","filing":"0001639691-17-000075","document":"wf-form4_150223632299871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969117000075/wf-form4_150223632299871.xml","form_type":"4"}},{"id":4239814,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-08T23:52:17.000Z","date":"2017-08-05","kind":"exercise","acquired":true,"shares":3327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person was granted restricted stock units (\"RSUs\") settled in ordinary share of LivaNova PLC (the \"Company\"), GBP 1.00 par value."}],"balance_after":15347,"source":{"system":"sec-edgar","filing":"0001639691-17-000075","document":"wf-form4_150223632299871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969117000075/wf-form4_150223632299871.xml","form_type":"4"}},{"id":4307756,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":49617,"kind":"person","name":"Novak Alfred J","position":1,"cik":"0001388862","reported_name":"Novak Alfred J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-23T21:43:41.000Z","date":"2017-05-22","kind":"sale","acquired":false,"shares":1000,"price":58.4868,"value":58486.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average selling price.  Securities sold through approximately two (2) separate sales on the transaction date at prices ranging from $58.4861 to $58.49.  The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12020,"source":{"system":"sec-edgar","filing":"0001639691-17-000053","document":"wf-form4_149557580606507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388862/000163969117000053/wf-form4_149557580606507.xml","form_type":"4"}}]}